Literature DB >> 31752757

Methodology of predicting novel key regulators in ovarian cancer network: a network theoretical approach.

Md Zubbair Malik1, Keilash Chirom2, Shahnawaz Ali3, Romana Ishrat3, Pallavi Somvanshi2, R K Brojen Singh4.   

Abstract

BACKGROUND: Identification of key regulator/s in ovarian cancer (OC) network is important for potential drug target and prevention from this cancer. This study proposes a method to identify the key regulators of this network and their importance.
METHODS: The protein-protein interaction (PPI) network of ovarian cancer (OC) is constructed from curated 6 hundred genes from standard six important ovarian cancer databases (some of the genes are experimentally verified). We proposed a method to identify key regulators (KRs) from the complex ovarian cancer network based on the tracing of backbone hubs, which participate at all levels of organization, characterized by Newmann-Grivan community finding method. Knockout experiment, constant Potts model and survival analysis are done to characterize the importance of the key regulators in regulating the network.
RESULTS: The PPI network of ovarian cancer is found to obey hierarchical scale free features organized by topology of heterogeneous modules coordinated by diverse leading hubs. The network and modular structures are devised by fractal rules with the absence of centrality-lethality rule, to enhance the efficiency of signal processing in the network and constituting loosely connected modules. Within the framework of network theory, we device a method to identify few key regulators (KRs) from a huge number of leading hubs, that are deeply rooted in the network, serve as backbones of it and key regulators from grassroots level to complete network structure. Using this method we could able to identify five key regulators, namely, AKT1, KRAS, EPCAM, CD44 and MCAM, out of which AKT1 plays central role in two ways, first it serves as main regulator of ovarian cancer network and second serves as key cross-talk agent of other key regulators, but exhibits disassortive property. The regulating capability of AKT1 is found to be highest and that of MCAM is lowest.
CONCLUSIONS: The popularities of these key hubs change in an unpredictable way at different levels of organization and absence of these hubs cause massive amount of wiring energy/rewiring energy that propagate over all the network. The network compactness is found to increase as one goes from top level to bottom level of the network organization.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31752757      PMCID: PMC6869253          DOI: 10.1186/s12885-019-6309-6

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  36 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

2.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Control of apoptosis by SMAR1.

Authors:  Md Zubbair Malik; Md Jahoor Alam; Romana Ishrat; Subhash M Agarwal; R K Brojen Singh
Journal:  Mol Biosyst       Date:  2017-01-31

Review 4.  Mucinous ovarian cancer: A therapeutic review.

Authors:  Wen Xu; Jack Rush; Kirsty Rickett; Jermaine I G Coward
Journal:  Crit Rev Oncol Hematol       Date:  2016-03-19       Impact factor: 6.312

5.  Adherence to treatment guidelines for ovarian cancer as a measure of quality care.

Authors:  Robert E Bristow; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Obstet Gynecol       Date:  2013-06       Impact factor: 7.661

6.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

Review 7.  EpCAM (CD326) finding its role in cancer.

Authors:  P A Baeuerle; O Gires
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

8.  Dynamical states, possibilities and propagation of stress signal.

Authors:  Md Zubbair Malik; Shahnawaz Ali; Soibam Shyamchand Singh; Romana Ishrat; R K Brojen Singh
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

9.  Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.

Authors:  Di Zhang; Peng Chen; Chun-Hou Zheng; Junfeng Xia
Journal:  Oncotarget       Date:  2016-01-26

10.  Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells.

Authors:  Hagen Kulbe; Francesco Iorio; Probir Chakravarty; Carla S Milagre; Robert Moore; Richard G Thompson; Gemma Everitt; Monica Canosa; Alexander Montoya; Denis Drygin; Ioana Braicu; Jalid Sehouli; Julio Saez-Rodriguez; Pedro R Cutillas; Frances R Balkwill
Journal:  Oncotarget       Date:  2016-03-29
View more
  5 in total

Review 1.  LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.

Authors:  Eleonora A Braga; Marina V Fridman; Alexey A Moscovtsev; Elena A Filippova; Alexey A Dmitriev; Nikolay E Kushlinskii
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

2.  Identification of key regulators in Sarcoidosis through multidimensional systems biological approach.

Authors:  Safia Tazyeen; Mohd Murshad Ahmed; Anam Farooqui; Aftab Alam; Md Zubbair Malik; Mohd Saeed; Irfan Ahmad; Mohammed Abohashrh; R K Brojen Singh; Romana Ishrat
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

3.  A Bioinformatics Approach to Identifying Potential Biomarkers for Cryptosporidium parvum: A Coccidian Parasite Associated with Fetal Diarrhea.

Authors:  Mumdooh J Sabir; Ross Low; Neil Hall; Majid Rasool Kamli; Md Zubbair Malik
Journal:  Vaccines (Basel)       Date:  2021-12-02

4.  Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis.

Authors:  Debasis Sahu; Subasa Chandra Bishwal; Md Zubbair Malik; Sukanya Sahu; Sandeep Rai Kaushik; Shikha Sharma; Ekta Saini; Rakesh Arya; Archana Rastogi; Sandeep Sharma; Shanta Sen; R K Brojen Singh; Chuan-Ju Liu; Ranjan Kumar Nanda; Amulya Kumar Panda
Journal:  Front Cell Dev Biol       Date:  2022-03-31

5.  CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach.

Authors:  Nirjhar Bhattacharyya; Samriddhi Gupta; Shubham Sharma; Aman Soni; Sali Abubaker Bagabir; Malini Bhattacharyya; Atreyee Mukherjee; Atiah H Almalki; Mustfa F Alkhanani; Shafiul Haque; Ashwini Kumar Ray; Md Zubbair Malik
Journal:  J Pers Med       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.